High quality API Entrectinib CAS 1108743-60-7

Entrectinib is an oral small molecule inhibitor of ALK kinase activity and is currently being used to evaluate its phase I/II clinical studies in the treatment of solid cancer.

Jinan Guoding Pharmaceutical Co., Ltd. is a company specilized in custom synthsis and contract research for Pharmaceutical Intermediates and APIs. We provides services such as technology development, technology transfer technical services. and also provides high quality products, based on the principle of quality first, integrity essential, customer service, and technological innovation, with innovation driven as the core, quality management as the guarantee, the company is aggressive and innovative, and is committed to providing customers with high-quality products and professional services.

Product Name:Entrectinib

CAS:1108743-60-7

Purity:98.0%

Molecular Formula:C31H34F2N6O2

Molecular Weight:560.638

Packing:Export worthy Packing

MSDS:Avaliable on request

Other Products of Our company:

1、Larotrectinib Intermediates

2、Entrectinib Intermediates

3、Repotrectinib Intermediates

4、Brigatinib Intermediates

5、Ibrutinib Intermediates

6、Praprofen Intermediates

7、Alectinib Intermediates

8、Amenmevir Interemdiates

9、Pyrazolopyrimidine Intermediates

10、Active Pharmaceutical Ingredient

Contact us if you need more details on Entrectinib Fda Approval. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Entrectinib and Larotrectinib、Entrectinib Breast Cancer. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Active Pharmaceutical Ingredient